Medicines, Poisons and Therapeutic Goods Act 2012
261Functions
Start here
Get a plain-English read of 261
Turn the raw legal text into a practical explanation grounded in Medicines, Poisons and Therapeutic Goods Act 2012.
261 Functions (1) The Committee's function is to give advice and make recommendations on issues relating to dealing with Scheduled substances. (2) Without limiting subsection (1), the Committee has the following functions: (a) to advise the CHO about the competency required by doctors to supply Scheduled substances; (b) to recommend to the CHO appropriate training programs for doctors who supply Scheduled substances; (c) to advise the CHO about the treatment of persons (whether generally or a particular person) with Scheduled substances; (d) to advise the CHO about issuing, varying, suspending and cancelling Schedule 4 or 8 authorisations for Scheduled substances; (e) to make recommendations to the CHO about matters to be included in codes of practice; (f) to advise the CHO about whether matters relating to the supply of a Scheduled substance should be referred to a National Health Practitioner Board established under the Health Practitioner Regulation National Law;
Medicines, Poisons and Therapeutic Goods Act 2012 145 (g) to advise the CHO about policy issues relating to the issue of prescriptions for the supply of, or the supply or use of, Scheduled substances; (h) to give other advice about Scheduled substances as conferred on it under this or another Act. Scheduled substance means: (a) a restricted Schedule 4 substance; or (b) a Schedule 8 substance.